Tor McCaul – Managing Director – Comet Ridge Limited (ASX: COI) is a publicly listed Australian energy company focused on the development of natural ga
Copyright 2023 – Finance News Network
Source: Finance News Network
27 Nov 2020 - Novatti Group Limited (ASX:NOV) Managing Director & CEO Peter Cook talks about the company's recently announced partnerships with UnionPay, Google Pay and Samsung Pay.
Read More16 Aug 2023 - Mark Leong - Executive Chairman - Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Read More10 Oct 2023 - Harry Fisher - Project Manager - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More08 May 2023 - Empire Energy Group Limited (ASX:EEG) Managing Director Alex Underwood discusses NT Government approval for fracking in the Beetaloo Basin, exemptions for small producers, traditional owners, pipelines, government funding and the company's pilot project.
Read More05 Mar 2024 - Chariot Corporation Limited (ASX:CC9) Managing Director Shanthar Pathmanathan discusses reasons behind the company's expansion of its Black Mountain holding.
Read More25 Nov 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses achieving a key reliability milestone for the company's laser diodes.
Read More11 Dec 2024 - INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
Read More23 Nov 2021 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen provides an introduction to the company's range of services to wholesale and retail clients.
Read More18 Dec 2019 - Oventus Medical Limited (ASX:OVN) Managing Director and CEO, Dr Chris Hart talks about the company's North American sales process via its lab in lab model and how this improves patient outcomes.
Read More01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
Read More
